Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,900
Closed -$598K 5162
2026
Q1
$598K Sell
40,900
-14,300
-26% -$210K ﹤0.01% 3759
2025
Q4
$698K Buy
55,200
+8,000
+17% +$118K ﹤0.01% 3753
2025
Q3
$726K Buy
47,200
+34,000
+258% +$548K ﹤0.01% 3656
2025
Q2
$208K Buy
+13,200
New +$200K ﹤0.01% 4041
2023
Q1
Sell
-38,700
Closed -$666K 4803
2022
Q4
$666K Buy
+38,700
New +$686K ﹤0.01% 3700

Other funds holding RXO

D.E. Shaw & Co's RXO Position: Q2 2026 in Review

D.E. Shaw & Co opened a new position in RXO (RXO) in Q2 2026: 542,415 shares worth $15M. The stake represents 0.01% of the portfolio and ranks #1502 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in RXO as recently as Q4 2024.

D.E. Shaw & Co first reported a position in RXO in Q3 2023 and has held it in 7 quarters since. 305 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • D.E. Shaw & Co held 542,415 shares of RXO worth $15M as of Q2 2026.
  • RXO was a new D.E. Shaw & Co position in Q2 2026.
  • RXO made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1502 holding.
  • D.E. Shaw & Co first reported a position in RXO in Q3 2023 and has held it in 7 quarters since.
  • 305 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.